Treatment of Alzheimer’s Disease: Trazodone, Sleep, Serotonin, Norepinephrine, and Future Directions
Open Access
- 12 February 2019
- journal article
- editorial
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 67 (3) , 923-930
Abstract
In this issue, an article by La et al. provides evidence that trazodone delayed cognitive decline in 25 participants with Alzheimer’s disease (AD), mild cognitive impairment, or normal cognition. For participants considered to have AD pathology, trazKeywords
This publication has 77 references indexed in Scilit:
- Leptin boosts cellular metabolism by activating AMPK and the sirtuins to reduce tau phosphorylation and β-amyloid in neuronsBiochemical and Biophysical Research Communications, 2011
- Leptin Does Not Directly Affect CNS Serotonin Neurons to Influence AppetiteCell Metabolism, 2011
- A Serotonin-Dependent Mechanism Explains the Leptin Regulation of Bone Mass, Appetite, and Energy ExpenditureCell, 2009
- The dorsal raphe nucleus shows phospho‐tau neurofibrillary changes before the transentorhinal region in Alzheimer's disease. A precocious onset?Neuropathology and Applied Neurobiology, 2009
- Leptin inhibits glycogen synthase kinase-3β to prevent tau phosphorylation in neuronal cellsNeuroscience Letters, 2009
- Sympathetic activation in broadly defined generalized anxiety disorderJournal of Psychiatric Research, 2008
- ApoE genotype accounts for the vast majority of AD risk and AD pathologyNeurobiology of Aging, 2004
- Alzheimer's Disease: Does Neuron Plasticity Predispose to Axonal Neurofibrillary Degeneration?New England Journal of Medicine, 1985
- Molecular Biology of Learning: Modulation of Transmitter ReleaseScience, 1982
- TrazodoneDrugs, 1981